Neoadjuvant radiotherapy and brachytherapy in endometrial cancer with gross cervical involvement: a CHIRENDO research group study.


Journal

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
ISSN: 1525-1438
Titre abrégé: Int J Gynecol Cancer
Pays: England
ID NLM: 9111626

Informations de publication

Date de publication:
01 2021
Historique:
received: 26 06 2020
revised: 28 09 2020
accepted: 30 09 2020
pubmed: 1 11 2020
medline: 17 12 2021
entrez: 31 10 2020
Statut: ppublish

Résumé

Historically, radical hysterectomy followed by adjuvant radiotherapy has been offered to patients with endometrial cancer who have gross cervical involvement; however, this approach is known to carry considerable morbidity. Neoadjuvant radiotherapy followed by extra-fascial hysterectomy has been proposed as an alternative treatment but has been poorly studied to date. To evaluate the locoregional control rate associated with neoadjuvant radiotherapy followed by extra-fascial hysterectomy. A retrospective cohort study of 30 patients with endometrial cancer with gross cervical involvement treated between May 2006 and January 2016 was performed. Eligible patients were those aged The median age was 60 (range 37-82) and median body mass index was 32 kg/m Neoadjuvant radiotherapy followed by extra-fascial hysterectomy offers good locoregional control with low treatment-related morbidity in patients with endometrial cancer with overt cervical involvement.

Sections du résumé

BACKGROUND
Historically, radical hysterectomy followed by adjuvant radiotherapy has been offered to patients with endometrial cancer who have gross cervical involvement; however, this approach is known to carry considerable morbidity. Neoadjuvant radiotherapy followed by extra-fascial hysterectomy has been proposed as an alternative treatment but has been poorly studied to date.
OBJECTIVE
To evaluate the locoregional control rate associated with neoadjuvant radiotherapy followed by extra-fascial hysterectomy.
METHODS
A retrospective cohort study of 30 patients with endometrial cancer with gross cervical involvement treated between May 2006 and January 2016 was performed. Eligible patients were those aged
RESULTS
The median age was 60 (range 37-82) and median body mass index was 32 kg/m
CONCLUSIONS
Neoadjuvant radiotherapy followed by extra-fascial hysterectomy offers good locoregional control with low treatment-related morbidity in patients with endometrial cancer with overt cervical involvement.

Identifiants

pubmed: 33127863
pii: ijgc-2020-001797
doi: 10.1136/ijgc-2020-001797
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

78-84

Informations de copyright

© IGCS and ESGO 2021. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Melica Nourmoussavi Brodeur (MN)

Department of Gynecologic Oncology, Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada.

Vanessa Samouëlian (V)

Department of Gynecologic Oncology, Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada.
Department of Medicine, Université de Montréal, Montreal, Quebec, Canada.

Yohann Dabi (Y)

Department of Gynecologic Oncology, Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada.

Béatrice Cormier (B)

Department of Gynecologic Oncology, Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada.
Department of Medicine, Université de Montréal, Montreal, Quebec, Canada.

Marie-Claude Beauchemin (MC)

Department of Medicine, Université de Montréal, Montreal, Quebec, Canada.
Department of Radiation Oncology, Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada.

Maroie Barkati (M)

Department of Medicine, Université de Montréal, Montreal, Quebec, Canada maroie.barkati.chum@ssss.gouv.qc.ca.
Department of Radiation Oncology, Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH